Valuation: PharmaEssentia Corporation

Market Cap 456B 13.83B 12.6B 11.61B 10.56B 19.81B 1,281B 20.81B 141B 56.14B 699B 51.89B 50.79B 2,195B P/E 2026 *
42x
P/E 2027 * 25.7x
Enterprise Value 433B 13.13B 11.96B 11.02B 10.02B 18.8B 1,216B 19.76B 134B 53.3B 664B 49.26B 48.22B 2,084B EV / Sales 2026 *
15.3x
EV / Sales 2027 * 9.78x
Free-Float
79.22%
Yield 2026 *
0.49%
Yield 2027 * 0.21%
1 day-8.71%
1 week-20.29%
Current month-7.56%
1 month-6.38%
3 months-21.43%
6 months+52.91%
Current year+159.62%
1 week 1,085
Extreme 1085.00000000
1,385
1 month 1,075
Extreme 1075
1,410
Current year 423.7
Extreme 423.699083
1,645
1 year 420.99
Extreme 420.994621
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 142.16
Extreme 142.160853
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member 73 2024-04-30
Director/Board Member - 2021-08-04
Director/Board Member - 2024-05-26
Change 5-day change 1-year change 3-year change Capi.($)
-8.71%-20.29%+161.01%+279.30% 13.83B
-2.49%-3.76%+53.38%+62.10% 63.66B
-0.63%-2.91%+6.55%+89.34% 58.56B
-2.37%-2.22%+21.77%+84.58% 54.19B
-2.19%-6.15%+12.43%+111.40% 44.66B
-1.89%-7.28%+9.30%+18.50% 40.51B
-0.93%-0.47%+19.34%+41.83% 36.27B
+1.11%-6.44%+127.46%+675.37% 34.87B
-0.80%+0.61%+76.27%+61.80% 32.26B
-2.17%+16.65%-28.89%+479.93% 31.01B
Average -2.11%-2.60%+45.86%+190.42% 41B
Weighted average by Cap. -1.72%-2.30%+36.19%+159.33%

Financials

2026 *2027 *
Net sales 28.21B 856M 779M 718M 653M 1.23B 79.24B 1.29B 8.74B 3.47B 43.28B 3.21B 3.14B 136B 43.09B 1.31B 1.19B 1.1B 998M 1.87B 121B 1.97B 13.35B 5.31B 66.11B 4.9B 4.8B 207B
Net income 10.92B 331M 302M 278M 253M 474M 30.66B 498M 3.38B 1.34B 16.75B 1.24B 1.22B 52.56B 17.96B 545M 496M 457M 416M 780M 50.44B 820M 5.56B 2.21B 27.55B 2.04B 2B 86.46B
Net Debt -23.05B -699M -637M -587M -534M -1B -64.74B -1.05B -7.14B -2.84B -35.36B -2.62B -2.57B -111B -34.24B -1.04B -946M -872M -793M -1.49B -96.18B -1.56B -10.61B -4.22B -52.54B -3.9B -3.82B -165B
Projected Income Statement - Annual - PharmaEssentia Corporation
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
26-11-20 NT$1,100.00 -8.71% 5,224,260
26-11-19 NT$1,205.00 -3.21% 3,604,921
26-11-18 NT$1,245.00 -2.73% 2,788,165
26-11-17 NT$1,280.00 -1.16% 3,852,848
26-11-16 NT$1,295.00 -6.16% 3,729,664
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - PharmaEssentia Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,100.00TWD
Average target price
1,481.27TWD
Spread / Average Target
+34.66%
  1. Stock Market
  2. Stocks
  3. 6446 Stock